Zacks: Brokerages Anticipate National Health Investors, Inc. (NYSE:NHI) to Announce $1.32 EPS


Share on StockTwits

Equities analysts expect National Health Investors, Inc. (NYSE:NHI) to announce $1.32 earnings per share for the current quarter, according to Zacks. Two analysts have made estimates for National Health Investors’ earnings. The highest EPS estimate is $1.36 and the lowest is $1.26. National Health Investors reported earnings per share of $1.36 in the same quarter last year, which would indicate a negative year-over-year growth rate of 2.9%. The company is scheduled to issue its next quarterly earnings results on Monday, May 10th.

According to Zacks, analysts expect that National Health Investors will report full-year earnings of $5.42 per share for the current fiscal year, with EPS estimates ranging from $5.15 to $5.56. For the next fiscal year, analysts anticipate that the firm will post earnings of $5.59 per share, with EPS estimates ranging from $5.29 to $5.73. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side research firms that that provide coverage for National Health Investors.

National Health Investors (NYSE:NHI) last announced its earnings results on Sunday, February 21st. The real estate investment trust reported $0.82 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.01 by ($0.19). The firm had revenue of $81.24 million for the quarter, compared to the consensus estimate of $84.22 million. National Health Investors had a return on equity of 12.64% and a net margin of 56.94%. National Health Investors’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same period in the previous year, the firm earned $1.41 EPS.

Several research analysts have issued reports on NHI shares. Zacks Investment Research lowered shares of National Health Investors from a “hold” rating to a “sell” rating in a research report on Wednesday, February 24th. Truist lifted their price target on shares of National Health Investors from $69.00 to $74.00 in a research report on Tuesday, March 23rd. Mizuho lowered shares of National Health Investors from a “neutral” rating to an “underperform” rating and decreased their price target for the stock from $56.00 to $55.00 in a research report on Wednesday, January 13th. Truist Securities lifted their price target on shares of National Health Investors from $69.00 to $74.00 in a research report on Tuesday, March 23rd. Finally, Wells Fargo & Company lifted their price target on shares of National Health Investors from $66.00 to $74.00 and gave the stock an “equal weight” rating in a research report on Monday, April 5th. Three research analysts have rated the stock with a sell rating and seven have issued a hold rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $66.40.

National Health Investors stock traded down $0.80 during mid-day trading on Friday, hitting $73.81. The company’s stock had a trading volume of 290,847 shares, compared to its average volume of 298,380. The company has a quick ratio of 13.13, a current ratio of 13.13 and a debt-to-equity ratio of 1.02. The stock has a market capitalization of $3.36 billion, a P/E ratio of 17.33 and a beta of 0.88. National Health Investors has a twelve month low of $44.27 and a twelve month high of $78.56. The stock’s fifty day moving average price is $73.48 and its two-hundred day moving average price is $67.16.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 7th. Shareholders of record on Wednesday, March 31st will be given a dividend of $1.102 per share. The ex-dividend date of this dividend is Tuesday, March 30th. This represents a $4.41 dividend on an annualized basis and a yield of 5.97%. National Health Investors’s payout ratio is presently 80.18%.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Marshall Wace North America L.P. acquired a new stake in National Health Investors during the 1st quarter worth about $31,000. International Assets Investment Management LLC acquired a new stake in National Health Investors during the 4th quarter worth about $32,000. Van ECK Associates Corp boosted its position in National Health Investors by 23.5% during the 3rd quarter. Van ECK Associates Corp now owns 1,298 shares of the real estate investment trust’s stock worth $78,000 after acquiring an additional 247 shares during the period. Selective Wealth Management Inc. acquired a new stake in National Health Investors during the 1st quarter worth about $105,000. Finally, LeJeune Puetz Investment Counsel LLC acquired a new stake in National Health Investors during the 4th quarter worth about $183,000. Hedge funds and other institutional investors own 65.72% of the company’s stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Further Reading: The Discount Rate – What You Need to Know

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.